Trending...
- Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874
- ThriveStack citedby launches Prompt Research to find the prompts buyers ask in AI search
- Global Leaders Convene in Seattle to Advance Responsible AI and Cross-Border Ecosystems
During PAD Awareness Month, Bend Oregon doctors urge people to get checked for peripheral artery disease and re-duce their risk of amputation.
BEND, Ore. - Washingtoner -- During the month of September, Peripheral Artery Disease (PAD) Awareness Month, Vascular Interventional Specialists of CORA will be partnering with other local medical providers in Central Oregon to promote awareness, screening, and treatment for PAD.
PAD is a chronic circulatory condition, which when left untreated can result in advanced disease and unnecessary limb amputation. PAD affects nearly 20 million Americans with an estimated 250,000 of them suffering avoidable amputation each year. A disproportionate number of these patients are from minority communities.
"PAD is a serious and yet often silent condition. Many patients don't have symptoms until the disease has advanced. That's why we want patients to be aware of health issues that contribute to the risk factors of PAD," said Dr. Benjamin English, Chief Vascular Specialist with Central Oregon Radiology Associates. By increasing PAD awareness in the Central Oregon community, Vascular Interventional Specialists of CORA hopes to improve access to screening and treatments, which has been shown to not only improve quality of life, but also dramatically lowers the risk of losing a limb.
More on Washingtoner
Dr English added that patients with diabetes, a history of smoking, high blood pressure, or high cholesterol are at greater risk for this condition. "We encourage patients to identify their risk and consider screening. Early detection and treatment is not only limb-saving, it can save lives as well," Dr. English stated.
For more information on PAD screenings, PAD doctors and treatment for PAD, visit: visofcora.com
PAD is a chronic circulatory condition, which when left untreated can result in advanced disease and unnecessary limb amputation. PAD affects nearly 20 million Americans with an estimated 250,000 of them suffering avoidable amputation each year. A disproportionate number of these patients are from minority communities.
"PAD is a serious and yet often silent condition. Many patients don't have symptoms until the disease has advanced. That's why we want patients to be aware of health issues that contribute to the risk factors of PAD," said Dr. Benjamin English, Chief Vascular Specialist with Central Oregon Radiology Associates. By increasing PAD awareness in the Central Oregon community, Vascular Interventional Specialists of CORA hopes to improve access to screening and treatments, which has been shown to not only improve quality of life, but also dramatically lowers the risk of losing a limb.
More on Washingtoner
- Spokane: Council Approves Additional Funding to Prepare for Inclement Weather
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration
- Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
- ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
Dr English added that patients with diabetes, a history of smoking, high blood pressure, or high cholesterol are at greater risk for this condition. "We encourage patients to identify their risk and consider screening. Early detection and treatment is not only limb-saving, it can save lives as well," Dr. English stated.
For more information on PAD screenings, PAD doctors and treatment for PAD, visit: visofcora.com
Source: Vascular Interventional Specialists of CORA
Filed Under: Health
0 Comments
Latest on Washingtoner
- The Great Junk Hunt Returns to Monroe: Kick Off Your Holiday Shopping at the Ultimate Vintage Treas
- AI Trading Agents Track Aerospace and Defense US Stocks Amid Rising Technology Investment (SATS, GILT, TSAT, IREN, JOBY, LUNR)
- KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
- Evluma's RoadMax Edge Roadway Luminaires Earn DarkSky Approved Status
- Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- Tacoma: Public Hearing for Off-Street Parking Code Update Set for December 1
- Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
- Spokane: SPD Makes an Arrest in Yesterday's Early Morning Shooting
- Spokane: Mayor Brown Introduces 2027-2028 Budget Proposal
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
- IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
- Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
- Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
- P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
- Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
- Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
- Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
- K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026